These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38804742)

  • 41. Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer.
    Joice GA; Bivalacqua TJ; Kates M
    Nat Rev Urol; 2019 Oct; 16(10):599-612. PubMed ID: 31434998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Updates on intravesical therapy.
    Pisano F; Vila Reyes H; Breda A; Palou J
    Curr Opin Urol; 2019 Nov; 29(6):649-655. PubMed ID: 31567439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis.
    Corsi NJ; Messing EM; Sood A; Keeley J; Bronkema C; Rakic N; Jamil M; Dalela D; Arora S; Piontkowski AJ; Majdalany SE; Butaney M; Rakic I; Li P; Menon M; Rogers CG; Abdollah F
    Clin Genitourin Cancer; 2022 Dec; 20(6):e498-e505. PubMed ID: 35871040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravesical Chemotherapy and Chemohyperthermia in Non-Muscle-Invasive Bladder Cancer; An Overview on Drug Administration Technologies and Pharmacokinetics.
    Campodonico F; Di Stasi S; Lev GM; Terrone C; Bongiovanni L; Mattioli F; Pagliarulo V; Introini C
    Curr Drug Metab; 2017; 18(7):657-665. PubMed ID: 28460622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge.
    Washburn DJ
    Clin J Oncol Nurs; 2007 Aug; 11(4):553-9. PubMed ID: 17723968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravesical electro-osmotic administration of mitomycin C.
    Di Stasi SM; Verri C; Celestino F; De Carlo F; Pagliarulo V
    Urologia; 2016 Oct; 83(Suppl 2):18-23. PubMed ID: 27716887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis and management of superficial bladder cancer.
    Amling CL
    Curr Probl Cancer; 2001; 25(4):219-78. PubMed ID: 11514784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non-muscle-invasive Bladder Cancer: A Propensity Score-matched Analysis.
    Fukuokaya W; Kimura T; Miki J; Kimura S; Watanabe H; Bo F; Okada D; Aikawa K; Ochi A; Suzuki K; Shiga N; Abe H; Egawa S
    Clin Genitourin Cancer; 2020 Apr; 18(2):e55-e61. PubMed ID: 31630978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer.
    Steinberg RL; Thomas LJ; O'Donnell MA
    Eur Urol Focus; 2018 Jul; 4(4):503-505. PubMed ID: 30017900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection: a prospective, randomized, multicenter study.
    Li NC; Ye ZQ; Na YQ;
    Chin Med J (Engl); 2013; 126(15):2805-9. PubMed ID: 23924446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
    Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
    J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adverse events after intravesical therapy: are we always ready to recognize and prevent them?].
    Fiorito C; Gontero P
    Urologia; 2013; 80 Suppl 21():27-32. PubMed ID: 23559132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder.
    DeCastro GJ; Sui W; Pak JS; Lee SM; Holder D; Kates MM; Virk RK; Drake CG; Anderson CB; James B; Abate-Shen CT; McKiernan JM
    J Urol; 2020 Aug; 204(2):247-253. PubMed ID: 32118506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical value of PSA increase during intravesical adjuvant therapy for nonmuscle-invasive bladder cancer.
    Serretta V; Gesolfo CS; Di Maida F; Caruana G; Rocchini L; Moschini M; Colombo R; Simonato A
    Urologia; 2016 Sep; 83(3):145-148. PubMed ID: 27516352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer.
    Lian F; Chen W; Liu Y; Shen L; Fan W; Cui W; Zhao Y; Li J; Wang Y
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1625-1633. PubMed ID: 30900154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.
    Steinberg RL; Thomas LJ; Brooks N; Mott SL; Vitale A; Crump T; Rao MY; Daniels MJ; Wang J; Nagaraju S; DeWolf WC; Lamm DL; Kates M; Hyndman ME; Kamat AM; Bivalacqua TJ; Nepple KG; O'Donnell MA
    J Urol; 2020 May; 203(5):902-909. PubMed ID: 31821066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy.
    Miyata Y; Sakai H
    Dis Markers; 2015; 2015():857416. PubMed ID: 26681820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what.
    Peyton CC; Chipollini J; Azizi M; Kamat AM; Gilbert SM; Spiess PE
    World J Urol; 2019 Oct; 37(10):2017-2029. PubMed ID: 30535583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.
    Gontero P; Oderda M; Mehnert A; Gurioli A; Marson F; Lucca I; Rink M; Schmid M; Kluth LA; Pappagallo G; Sogni F; Sanguedolce F; Schiavina R; Martorana G; Shariat SF; Chun F
    J Urol; 2013 Sep; 190(3):857-62. PubMed ID: 23545101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon alfa in the treatment paradigm for non-muscle-invasive bladder cancer.
    Lamm D; Brausi M; O'Donnell MA; Witjes JA
    Urol Oncol; 2014 Jan; 32(1):35.e21-30. PubMed ID: 23628309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.